The store will not work correctly when cookies are disabled.
N-[4-(Diethylamino)phenyl]thieno[2,3-d][1,2,3]thiadiazole-6-carboxamide
ID: ALA4564721
PubChem CID: 155560086
Max Phase: Preclinical
Molecular Formula: C15H16N4OS2
Molecular Weight: 332.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc(NC(=O)c2csc3nnsc23)cc1
Standard InChI: InChI=1S/C15H16N4OS2/c1-3-19(4-2)11-7-5-10(6-8-11)16-14(20)12-9-21-15-13(12)22-18-17-15/h5-9H,3-4H2,1-2H3,(H,16,20)
Standard InChI Key: CMFWFDPMQRFIQK-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
16.8034 -25.5020 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.7972 -26.3233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5761 -26.5835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0632 -25.9201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5861 -25.2536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8845 -25.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2930 -26.6392 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1143 -26.6441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5163 -27.3575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3369 -27.3627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7547 -26.6528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3418 -25.9361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5226 -25.9344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5760 -26.6566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9813 -27.3703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8026 -27.3741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9879 -25.9467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8092 -25.9505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3015 -25.2156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5681 -27.4049 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.7842 -27.6497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3063 -26.9839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
4 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
11 14 1 0
14 15 1 0
15 16 1 0
14 17 1 0
17 18 1 0
6 19 2 0
3 20 1 0
20 21 1 0
21 22 2 0
2 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.45 | Molecular Weight (Monoisotopic): 332.0766 | AlogP: 3.85 | #Rotatable Bonds: 5 |
Polar Surface Area: 58.12 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.44 | CX Basic pKa: 5.43 | CX LogP: 3.83 | CX LogD: 3.82 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.77 | Np Likeness Score: -2.34 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |